Following our previous molecular modeling studies we herein report the synthesis of substituted 1,2,3,4-tetrahydroisoquinolinone-4-carboxylic acids in an attempt to obtain new anticonvulsants acting as negative modulators of AMPA-type glutamate receptor. The evaluation of their pharmacological effects demonstrated that some derivatives were able to prevent audiogenic induced seizures in DBA/2 mice.
Introduction
L-Glutamate (Glu) is the major excitatory neurotransmitter in the mammalian central nervous system. Glu interacts with two different classes of receptors, ionotropic receptors (iGluRs) and metabotropic receptors (mGluRs). iGluRs are ligand-gated cationic channels which cause neuronal depolarization by generating fast excitatory postsynaptic potentials, while mGluRs are coupled to G proteins and have a modulatory role in neurotransmission.
The iGluRs are subdivided into three primary families on the basis both of the molecular composition and of the exogenous agonist which preferentially activates the receptor: N-methyl-D-aspartate (NMDA), kainate (KA) and 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionate (AMPA).
The observation that excessive activation of the iGluRs may be involved in the pathogenesis of many forms of epilepsy prompted an intense effort on the development of iGluR antagonists as potential anticonvulsant agents. [3] [4] A selective noncompetitive blockade of AMPA receptor (AMPAR) was shown by some 2,3-benzodiazepine derivatives (Figure 1) , [5] [6] [7] [8] [9] [10] such as the prototype of this family of ligands, 1-(4'-aminophenyl)-4-methyl-7,8-methylenedioxy-5H-2,3-benzodiazepine (1, GYKI 52466), and in particular 3-N-acetyl-1-(4'-aminophenyl)-4-methyl-7,8-methylenedioxy-4,5-dihydro-2,3-benzodiazepine (2, Talampanel), which aroused great interest as an anticonvulsant agent and phase II/III clinical trials of which are under way. 11 In our search for new AMPAR negative modulators, [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] Considering that only a little information is available concerning the interaction mechanism of positive and negative modulators 22 and in the absence of three-dimensional structure-based information, we recently developed 23 Our pharmacophore hypothesis was successfully used to design new noncompetitive AMPAR antagonists and led to the discovery of 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives as new potent anticonvulsant agents. [24] [25] [26] In particular, the 2-acetyl-1-(4-chlorophenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline 6 ( Figure 1 ) was characterized by improved pharmacological effects when compared in in vivo and in vitro tests with other current AMPAR antagonists. 24, 25 Furthermore, the model obtained was used as a query for virtual screening on 3D-databases; selected molecules were tested and PD00735 27 (Figure 2 ), containing the 1,2,3,4-tetrahydroisoquinolin-1-one skeleton, showed the most interesting anticonvulsant efficacy. Chemical structure of PD00735 and its alignment into pharmacophore hypothesis. As shown in Figure 2 , the four-feature pharmacopore model is well-mapped by PD00735: i) the carboxylic acid function overlaps with the hydrogen bond acceptor site; ii) the benzene-fused ring is positioned over the aromatic feature; iii) the benzyl and phenyl substituents on the tetrahydroisoquinolinone skeleton correspond to the two hydrophobic areas.
Using PD00735 as template, we planned and performed the synthesis of 1,2,3,4-tetrahydroisoquinolinone-4-carboxylic acids and corresponding ethyl esters to obtain new noncompetitive antagonists with higher biological efficacy. Structural and stereochemical features as well as the results of preliminary pharmacological screening of compounds synthesized are also herein reported.
Results and Discussion
As described in Scheme 1, the tetrahydroisoquinolinone-4-carboxylic acids 9 structurally related to PD00735 were easily synthesized employing well-known procedures from the corresponding imines and homophthalic anhydride. [28] [29] [30] [31] The products 9 possess two asymmetric centres (C-3 and C-4) and therefore could exist as cis-or trans-diastereoisomers. When we treated the suitable imine 7a-k with homophthalic anhydride 8a-k in chloroform at room temperature, only the cis diastereoisomer was generally recovered. On the contrary, in some cases using more drastic conditions (i.e boiling toluene), the reaction mixture afforded trans-diasteroisomer. As previously reported 30 this latter can be recovered by isomerization of cis-isomer on heating in acetic acid (e.g. 9e).
Only trans-diastereoisomers have been isolated during the preparation of ethyl esters 10a-f and 10j-k by treatment with diethylsulfate in alcaline medium.
The stereochemical configurations of the substituents at C-3 and C-4 were established on the basis of coupling constants observed in proton NMR spectrum for the two protons at C3 and C4. In particular, the cis relative configuration was established from the two doublets with a coupling constant of ~ 6 Hz observed close to 4 ppm and 5.5 ppm, while in the corresponding trans diastereoisomers the H 3 and H 4 hydrogens appear as two singlets. 
Scheme 1
Although the stereochemical control of reaction has been studied and reported by different authors, the exact mechanism of the cyclocondensation process is far to be clarified; it is known that both the reaction conditions (solvent polarity, temperature, etc.) and the nature of reagents employed influences the stereochemistry; in fact, the electronic and steric effects determine the stereochemical outcome of the reaction of Schiff bases 7 with homophthalic anhydride 8. In particular, the bulk ot the N-substituent of the imine has an effect on the ratios of the E-and Zisomer and thus on the ratios of the diastereoisomers formed. 29 In our case the presence of a ISSN 1424-6376 Page 174 © ARKAT USA, Inc methylene group between the nitrogen atom and R 2 reduces the steric hindrance thus preferentially affording cis-isomers. The anticonvulsant effects of some selected 1,2,3,4-tetrahydroisoquinolinones 9-10 were evaluated after intraperitoneal (ip) administration against audiogenic seizures in DBA/2 mice, which are considered an excellent animal model for generalized epilepsy and for screening new anticonvulsant drugs. 32 The results of anticonvulsant test were reported in Table 1 and compared with those of well known noncompetitive AMPA receptor antagonists such as GYKI 52466 (1), talampanel (2), CFM-2 (3) as well as compound PD00735 (9f). As shown in Table 1 the preliminary pharmacological screening pointed out that among this class of compounds only 9d and 10d showed significant activity. Moreover, the evaluation of the ED 50 values of 10f suggested that the presence of the ethyl carboxylate moiety negatively influences the anticonvulsant properties. In conclusion new 1,2,3,4-tetrahydroisoquinoline-4-carboxylic acids and carboxylates were synthesized and the different diastereoisomers were separated and characterized. Some of them showed anticonvulsant properties. General procedure for the synthesis of ethyl 1,2,3,4-tetrahydro-1-oxoisoquinoline-4-carboxylates Diethyl sulfate (1.3 mmol) was added to a suspension of suitable 1,2,3,4-tetrahydroisoquinoline-4-carboxylic acid 9 (1.3 mmol) and potassium carbonate (1.3 mmol) in dioxane and refluxed for 1h. In particular, compounds 9a-e and 9k were cis-isomers, 9f was a mixture of diastereoisomers, and 9j was trans-isomer. The reaction mixture was extracted with diethyl ether and washed with a NaHCO 3 saturated aqueous and then with water. The organic layer was dried (sodium sulfate) and evaporated under reduced pressure leaving an oil which was crystallized with ethyl ether to give only trans-isomer.
